Prescribing rates and characteristics of recipients of tenofovir-containing regimens before and after market entry of tenofovir alafenamide.

导出 LinkOut

翻译打印收藏纠错

作者： Anna,Hung ^[1] ; Matthew,Sinclair ^[2] ; Marion,Hemmersbach-Miller ^[3] ; Daniel,Edmonston ^[2] ; Christina,Wyatt ^[2]

作者单位： Duke Clinical Research Institute and Department of Population Health Sciences, Duke University, Durham, NC. ^[1] Duke Clinical Research Institute and Department of Medicine, Division of Nephrology, Duke University, Durham, NC. ^[2] Duke Clinical Research Institute and Duke Division of Infectious Diseases, Duke University, Durham, NC. ^[3]

主题词丙氨酸(Alanine);抗HIV药(Anti-HIV Agents);抗病毒药(Antiviral Agents);共病现象(Comorbidity);药物批准(Drug Approval);HIV感染(HIV Infections);人类(Humans);美国(United States);美国食品和药物管理局(United States Food and Drug Administration)

DOI 10.18553/jmcp.2020.26.12.1582

PMID 33251997

发布时间 2023-08-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览9

Journal of managed care & specialty pharmacy

2020年26卷12期

1582-1588页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Prescribing rates and characteristics of recipients of tenofovir-containing regimens before and after market entry of tenofovir alafenamide.

Journal of managed care & specialty pharmacy

相似文献

Journal of managed care & specialty pharmacy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Prescribing rates and characteristics of recipients of tenofovir-containing regimens before and after market entry of tenofovir alafenamide.

Journal of managed care & specialty pharmacy

相似文献

Journal of managed care & specialty pharmacy

相关期刊

检索历史清除